Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | 4,267,564 | reported | 02 Oct 2020 | tx 11+5,193,850−4,114,962 |
| scPharmaceuticals Inc. | 2,576,532 | reported | 21 Nov 2017 | tx 2+2,576,532−18,500,000 |
| INSULET CORP | 1,568,841 | reported | 18 May 2007 | tx 2+1,568,841−1,568,841 |
| AVANIR PHARMACEUTICALS | 50,683 | reported | 01 Mar 2007 | tx 7+51,379−1,258,242 |
| Audentes Therapeutics, Inc. | 18,000 | reported | 24 Aug 2016 | tx 10+4,595,400−4,544,066 |
| Adicet Bio, Inc. | 14,414 | reported | 03 Jun 2020 | tx 7+4,859,215−4,297,051 |
| NxStage Medical, Inc. | 14,000 | reported | 27 May 2010 | tx 3+39,667 |
| Roka BioScience, Inc. | 3,962.26 | reported | 21 Sept 2016 | tx 24+8,978,983−30,973,900 |
| INTERCEPT PHARMACEUTICALS INC | 1,259 | reported | 24 Nov 2015 | tx 91+12,673,418−11,536,832 |
| Relypsa Inc | 0 | reported | 20 Nov 2013 | tx 19+11,713,544−10,419,539 |
4 purchases reported after at least 12 months of silence — most recent on 03 Feb 2020.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Oct 2020 | PURCHASE | Arcutis Biotherapeutics, Inc. | 296,000 | 25.00 USD | |
| 02 Oct 2020 | PURCHASE | Arcutis Biotherapeutics, Inc. | 200,000 | 25.00 USD | |
| 03 Jun 2020 | GRANT_AWARD | Adicet Bio, Inc. | 14,414 | 0.00 USD | deriv |
| 27 Feb 2020 | GRANT_AWARD | Arcutis Biotherapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 04 Feb 2020 | CONVERSION | Arcutis Biotherapeutics, Inc. | 429,786 | — | |
| 04 Feb 2020 | CONVERSION | Arcutis Biotherapeutics, Inc. | 2,825,603 | — | |
| 04 Feb 2020 | CONVERSION | Arcutis Biotherapeutics, Inc. | 859,573 | — | |
| 03 Feb 2020 | PURCHASE | Arcutis Biotherapeutics, Inc. | 382,388 | 17.00 USD | first after silence |
| 03 Feb 2020 | PURCHASE | Arcutis Biotherapeutics, Inc. | 176,500 | 17.00 USD | |
| 04 Feb 2020 | CONVERSION | Arcutis Biotherapeutics, Inc. | 859,573 | 0.00 USD | deriv |
| 04 Feb 2020 | CONVERSION | Arcutis Biotherapeutics, Inc. | 2,825,603 | 0.00 USD | deriv |
| 04 Feb 2020 | CONVERSION | Arcutis Biotherapeutics, Inc. | 429,786 | 0.00 USD | deriv |
| 21 Nov 2019 | OTHER | AVEDRO INC | 4,240,128 | — | |
| 21 Nov 2019 | OTHER | AVEDRO INC | 8,314 | — | deriv |
| 21 Nov 2019 | OTHER | AVEDRO INC | 3,005 | — | deriv |
| 14 Jun 2019 | GRANT_AWARD | AVEDRO INC | 3,005 | 0.00 USD | deriv |
| 08 May 2019 | GRANT_AWARD | Adicet Bio, Inc. | 14,414 | 0.00 USD | deriv |
| 19 Feb 2019 | CONVERSION | AVEDRO INC | 333,178 | — | |
| 19 Feb 2019 | CONVERSION | AVEDRO INC | 383,746 | — | |
| 19 Feb 2019 | CONVERSION | AVEDRO INC | 3,370,786 | — | |
| 19 Feb 2019 | CONVERSION | AVEDRO INC | 333,178 | 0.00 USD | deriv |
| 19 Feb 2019 | CONVERSION | AVEDRO INC | 383,746 | 0.00 USD | deriv |
| 19 Feb 2019 | CONVERSION | AVEDRO INC | 3,370,786 | 0.00 USD | deriv |
| 19 Feb 2019 | GRANT_AWARD | AVEDRO INC | 8,314 | 0.00 USD | deriv |
| 05 Mar 2018 | SALE | GLAUKOS Corp | 1,220 | 32.05 USD |